Accroissement des propriétés pharmacodynamiques d'un immunosuppresseur ciblant sélectivement CD28 – APIC28
Project coordination
(PME (petite et moyenne entreprise))
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 184,193 euros
Beginning and duration of the scientific project:
- 36 Months